Abstract:Objective: We aimed to explore the correlations between and possible mechanisms of common environmental endocrine disruptors, phthalates, and ovarian dysfunction in endometriosis. Methods: Subjects were included in the case group ( n = 107) who were diagnosed with endometriosis by postoperative pathology in Fujian Maternal and Child Hospital from February 2018 to February 2021, and the women who were excluded from endometriosis by surgery were as the control group ( n = 70). The demographic information of the subjects were evaluated by questionnaire, and the clinical characteristics were evaluated by medical records and 3-year follow-up results. Gas chromatography‒mass spectrometry was used to quantify 10 metabolites of phthalates, including dimethyl ortho-phthalate (DMP), mono-n-methyl phthalate (MMP), dioctyl ortho-phthalate (DEP), mono-ethyl phthalate (MEP), di-n-butyl ortho-phthalate (DBP), mono-butyl phthalate (MBP), benzylbutyl phthalate (BBzP), mono-benzyl; phthalate (MBzP), diethylhexyl phthalate (DEHP) and mono-ethylhexyl phthalate (MEHP), in the urine samples of the subjects. Furthermore, a total of 54 SD rats were exposed to DEHP 0, 5, 50, 100, 250, 500, 1,000, 2000, and 3,000 mg/kg/day for 2 weeks. The SD rats' body weight, oestrus cycle changes, and serum anti-mullerian hormone (AMH) levels were evaluated. After sacrifice, the mass index of the rat uterus and bilateral ovaries were calculated. Finally, bioinformatics analysis of rat ovarian tissues was performed to explore the possible mechanism. SPSS 24.0 (IBM, United States) was used for data analysis. p -value <0.05 was considered statistically significant. Results: The human urinary levels of DMP ( p < 0.001), MMP ( p = 0.001), DEP ( p = 0.003), MEP ( p = 0.002), DBP ( p = 0.041), MBP ( p < 0.001), BBzP ( p = 0.009), DEHP ( p < 0.001), and MEHP ( p < 0.001) were significantly higher in women with endometriosis than in controls. Notably, DEHP was a significant risk factor for endometriosis (OR: 11.0, 95% CI: 5.4–22.6). The area under the ROC curve increased when multiple phthalates were diagnosed jointly, reaching 0.974 as the highest value, which was helpful for the diagnosis of endometriosis. In vivo experiments showed that after DEHP exposure in rats, the mass index of the ovary and uterus decreased in a dose-dependent manner; the oestrus cycle of SD rats was irregularly prolonged and disordered; and the serum AMH level was negatively correlated with the DEHP exposure dose (Rho = −0.8, p < 0.001). Bioinformatics analysis of rat ovarian tissues showed that seven genes involved in the steroid biosynthesis pathway were upregulated and may play a negative role in ovarian function. Conclusion: Exposure to phthalates, especially DEHP, is associated with the occurrence of endometriosis and affects women's reproductive prognosis and ovarian function. The steroid biosynthesis pathway may be related to ovarian dysfunction. The detection of phthalate in urine may become a new biological target for the diagnosis of endometriosis.

Phthalate exposure and risk of ovarian dysfunction in endometriosis: human and animal data

Association between Diethylhexyl Phthalate Exposure with Folliculogenesis and Ovarian Steroidogenesis: A Systematic Review and Meta-Analysis

The Effects of Di(2-Ethylhexyl) Phthalate Exposure in Women with Polycystic Ovary Syndrome Undergoing in Vitro Fertilization

Role of the 17Β-Hydroxysteroid Dehydrogenase Signalling Pathway in Di-(2-ethylhexyl) Phthalate-Induced Ovarian Dysfunction: an in Vivo Study.

Association Between Phthalate Metabolites And Risk Of Endometriosis: A Meta-Analysis

Relationship between phthalates exposure, risk of decreased ovarian reserve, and oxidative stress levels

Impact of DEHP on Mitochondria-Associated Endoplasmic Reticulum Membranes and Reproductive Toxicity in Ovary

Association between the Exposure to Phthalates and the Risk of Endometriosis: An Updated Review

Urinary Levels of Phthalate Metabolites in Women Associated with Risk of Premature Ovarian Failure and Reproductive Hormones.

Epidemiologically relevant phthalates affect human endometrial cells in vitro through cell specific gene expression changes related to the cytoskeleton and mitochondria

Correlation between Serum Phthalate Concentration and Endometriosis

Bisphenol A and Phthalates and Endometriosis: the Endometriosis: Natural History, Diagnosis and Outcomes Study.

Dysregulation of Steroid Metabolome in Follicular Fluid Links Phthalate Exposure to Diminished Ovarian Reserve of Childbearing-Age Women

The association of serum phthalate metabolites with biomarkers of ovarian reserve in women of childbearing age

Di‐(2‐ethylhexyl) phthalate exposure induces female reproductive toxicity and alters the intestinal microbiota community structure and fecal metabolite profile in mice

Exposure to environmental doses of DEHP causes phenotypes of polycystic ovary syndrome

The Inflammation Response to DEHP Through PPARγ in Endometrial Cells.

Phthalate Exposure in Association with Serum Hormone Levels, Sperm DNA Damage and Spermatozoa Apoptosis: A Cross-Sectional Study in China

Foetal-neonatal Exposure of Di (2-Ethylhexyl) Phthalate Disrupts Ovarian Development in Mice by Inducing Autophagy.

Phthalate exposure as a hidden risk factor for uterine leiomyoma in adult women: Accumulated evidence from observational studies

Di-2-ethylhexyl phthalate (DEHP) exposure increase female infertility